Table of Contents Table of Contents
Previous Page  146 / 172 Next Page
Information
Show Menu
Previous Page 146 / 172 Next Page
Page Background

Abstracts of the 22

nd

National Congress of Digestive Diseases / Digestive and Liver Disease 48S2 (2016) e67–e231

e207

P.16.4

ENDOSCOPIC ULTRASOUND-GUIDED TRANSMURAL STENTING

FOR GALLBLADDER DRAINAGE IN HIGH RISK PATIENTS WITH

ACUTE CHOLECYSTITIS: A SYSTEMATIC REVIEW AND POOLED

ANALYSIS

Anderloni A.*

1

, Buda A.

2

, Vieceli F.

2

, Khashab M.A.

3

, Hassan C.

4

,

Repici A.

1

1

Humanitas Research Hospital, Milano, Italy,

2

Ospedale Santa Maria

del Prato, Feltre, Italy,

3

The Johns Hopkins Medical Institutions,

Baltimore, MD, United States,

4

Ospedale Nuovo Regina Margherita,

Roma, Italy

Background and aim:

Endoscopic ultrasound-guided transmural

stenting for gallbladder drainage is an emerging alternative for the

treatment of acute cholecystitis in high risk surgical patients. A

variety of stents have been described, including plastic stents, self-

expandable metal stents (SEMSs), and lumen-apposing metal stents

(LAMSs). LAMSs represent the only specifically designed stent for

transmural gallbladder drainage. A systematic reviewwas performed

to evaluate the feasibility and efficacy of EUS-guided drainage (EUS-

GBD) in acute cholecystitis using different type of stents.

Material and methods:

A computer-assisted literature search up

to September 2015 was performed using two electronic databases,

MEDLINE and Embase. Search terms included MeSH and non-

MeSH terms relating to acute cholecystitis, gallbladder drainage,

endoscopic gallbladder drainage, endoscopic ultrasound gallbladder

drainage, alone or in combination. Additional articles were retrieved

by hand-searching from references of relevant studies. Pooled

technical, clinical and adverse event rates were estimated using all

included studies.

Results:

Twenty-one studies met the inclusion criteria and the

eligible cases were 166. The overall technical success rate, clinical

success rate and frequency of adverse events were 95.8%, 93.4%

and 12.0%, respectively. The technical success rate was 100% using

plastic stents, 98.6% using SEMSs and 91.5% using LAMSs. The

clinical success rate was 100%, 94.5% and 90.1% after the deployment

of plastic stents, SEMSs and LAMSs respectively. The frequency of

adverse events was 18.2% using plastic stents, 12.3% using SEMSs

and 9.9% using LAMSs.

Conclusions:

Among the different drainage approaches in the non-

surgical management of acute cholecystitis, EUS-guided transmural

stenting for gallbladder drainage appears to be feasible, safe and

effective. LAMSs seem to have high potentials in terms of efficacy

and safety, although further prospective studies are needed.

P.16.5

TRANSORAL OUTLET REDUCTION FOR THERAPY OF WEIGHT

REGAIN AFTER GASTRIC BYPASS

Boskoski I.*, Familiari P., Tringali A., Landi R., Perri V.,

Costamagna G.

Ospedalle Gemelli, Roma, Italy

Background and aim:

Enlargement of gastrojejunal anastomosis

aperture is associated with weight regain in patients with Roux-

en-Y gastric bypass (RYGB). Endoscopic transoral outlet reduction

(TORe) has proven safe and effective for treatment of weight regain.

The objective of this study was to evaluate the results of endoscopic

outlet reduction in single Italian center.

Material and methods:

The series included consecutive post-RYGB

patients with weight regain and enlarged gastrojejunal anastomosis

aperture (>15 mm). Endoscopic reduction was performed with a

full-thickness endoscopic suturing device at our endoscopy unit.

Results:

Nineteen patients who had regained weight after gastric

bypass (BMI > 35) underwent TORe from January to September 2015.

Baseline mean BMI was 36.8 (range 33-43.6) and weight was 104.5

kg (range 85-131). The procedure was done with the Overstitch

device (Apollo Endosurgery) and Olympus double channel operative

endoscope. An Overtube (US Endoscopy) was placed before the

procedure in all patients. Before suturing the outlet rims were

cauterized with pulsed pulsed Argon Plasma (ERBE Vio 200) on 40

Watts in all patients. Mean procedure time was 35 minutes (range

15-60) and a mean number of 2.3 stitches per patient were placed

(range 2-4) on the level of the gastric outlet. After suturing the

patency of the new redone outlet was tested with standard

gastroscope. There were three (15.7%) complications of which two

were mild (one intraoperative bleeding that arrested spontaneously

and fever due to small retrogastric collection treated with

antibiotics), while one patient (5.2%) had gastric perforation that

required urgent surgery. Mean hospital stay was 2.8 days (range

2-10). Telephonic follow-up was done at 1, 3 and 6 months. Mean

BMI at 1 month follow-up was 33.8, at 3 months was 32.4 while at 6

months was 32.3. Figure 1 shows the BMI during follow-up for each

patient.

Conclusions:

In our experience TORe was safe and effective

procedure in patients with weight regain after RYGB. Longer follow-

up is needed to establish the durability of these results. Further

studies are however needed to better understand the role of TORe

after RYGB and the proper selection of patients.

P.16.6

ENDOSCOPIC TREATMENT WITH SELF EXPANDABLE METAL

STENT OF NEOPLASTIC COLONIC STRICTURES

Bucciero F.*, Fonte G., Manetti R., Talamucci L., Naspetti R.

AOU Careggi, Firenze, Italy

Background and aim:

To evaluate the clinical efficacy of endoscopic

treatment of neoplastic colonic strictures with self expandable

metal stents (SEMS) positioned with palliative intent or “bridge to

surgery”.

Material and methods:

We placed SEMS for the treatment of

neoplastic stenosis from July 2009 to April 2015 c/o the Digestive

Endoscopy and Surgery Rooms of AOU Careggi in Florence.

Results:

We placed 90 SEMS for the treatment of neoplastic stenosis

from July 2009 to April 2015 c/o the Digestive Endoscopy and

Surgery Rooms of AOU Careggi in Florence.

Patients were 85, including 42 women and 43 men with an average

age of 76 years.

45 stents were placed as “bridge to surgery” and elective surgery

was performed after 30 days (range 9-180 days), 45 stents were

placed with palliative intent.